Loading clinical trials...
Loading clinical trials...
A Retrospective/Prospective Analysis of Characterization of the Long-Term Responders on Olaparib in Solid Tumours
Conditions
Locations
8
Australia
South Eastern Sydney Local Health District
Randwick, New South Wales, Australia
British Columbia Cancer Centre
Vancouver, British Columbia, Canada
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Institute of European Oncology
Milan, Italy
Vall d'Hebron
Barcelona, Spain
Start Date
February 1, 2016
Primary Completion Date
June 16, 2021
Completion Date
August 31, 2022
Last Updated
January 10, 2023
NCT06915025
NCT06710548
NCT02637934
NCT05080946
NCT04657068
NCT05281471
Lead Sponsor
University Health Network, Toronto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions